Full Approval News Today

The FDA granted full approval to tisotumab vedotin for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.

RUBY-3 findings support povetacicept’s ability to induce remission, reduce UPCR, stabilize renal function, and resolve hematuria in patients with IgAN.

Nearly fifteen months after Colorado voters approved the Natural Medicine Health Act, the public got its first glimpse of draft rules that will govern the regulated psychedelics program...

Jaguar Health Announces FDA Agrees with Clinical Trial Protocol for ...

From newsworthy moments to groundbreaking research, these were the most-read Alzheimer disease-related articles on Pharmacy Times in 2023.

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced ...

Jaguar Health Names Principal Investigators for Clinical Trial to Support ...

Unveiling the child labor scandal: Minnesota factory, Monogram Food Solutions, faces penalties for endangering teens, sparking nationwide calls for compliance with labor laws.

The FDA approved Leqembi for people with early Alzheimer's disease on Thursday, making it easier for older adults to obtain the first drug to slow memory and thinking issues.